http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9839754-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75b86e50a7529f6158517db14a0b81df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e53a1ac124454447fb0ee022615a526f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-3569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2230-432
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-3592
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-582
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-082
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2016-0015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-502
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2016-0024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2016-0027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2016-0021
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-00
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M16-00
filingDate 2010-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5ed28237e9c31eaacfa2342b2c6261f
publicationDate 2017-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-9839754-B2
titleOfInvention System for providing support therapy while determining concentrations of a molecular gaseous expired by a subject receiving pressure support therapy
abstract Pressure support therapy is provided to a subject. The effectiveness of the provided pressure support therapy is determined and/or the therapy is titrated based on determinations of the concentration of one or more gaseous molecular species in gas exhaled by the subject. The determinations of composition of gas exhaled by the subject are obtained from samples with relatively little distortion caused by dilution of expired gases from gases provided to the airway of the subject as part of the pressure support therapy.
priorityDate 2009-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012234324-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006012205-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002104536-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006042638-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009301488-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007068528-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007062531-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0728493-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6105575-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457698762
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID280

Total number of triples: 38.